Pharmaceutical

Alexion and Verge enter AI-powered drug discovery deal

Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.

Sep 11, 2023 - 20:00
Alexion and Verge enter AI-powered drug discovery deal
Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.
Read the original article

Tags:

Previous Article

Janssen seeks EMA authorisation for urothelial cancer treatment

Next Article

Moderna Forms Multi-Billion Dollar Strategic Partnership with Immatics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The highs — and lows — of JPM 2024 you should pay attention to

The highs — and lows — of JPM 2024 you should pay atten...

Jan 12, 2024

The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option

The U.K. just cleared a drug to prevent breast cancer. ...

Nov 13, 2023

STAT+: GSK is replacing its popular Flovent inhaler with authorized generics, raising cost concerns for asthma patients

STAT+: GSK is replacing its popular Flovent inhaler wit...

Jan 6, 2024